# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001140361-25-014874
Filing Date
2025-04-22
Accepted
2025-04-22 13:44:13
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-22

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | ny20044429x3_ars.pdf | ARS | 1375661
| Complete submission text file | 0001140361-25-014874.txt |  | 1896307

Mailing Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130
Business Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130 (619) 949-3681
GYRE THERAPEUTICS, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 000-51173 | Film No.: 25856818
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)